A new approach to managing chemotherapy-related anemia: nursing implications of epoetin alfa.
OBJECTIVE
To review the role of epoetin alfa (recombinant human erythropoietin) in the treatment of chemotherapy-related anemia and the nursing management of patients receiving this form of therapy.


METHODS
Published books, journal articles, and monographs as well as clinical experience.


RESULTS
Anemia is a common problem for patients with cancer. Successful management of anemia associated with cancer chemotherapy can lead to improved quality of life for patients during therapy.


CONCLUSIONS
The use of epoetin alfa to treat the anemia associated with cancer chemotherapy represents a viable new therapeutic alternative to the use of transfusions. Oncology nurses play an important role in shaping care strategies for patients receiving cancer therapy.


CONCLUSIONS
The nurse's role in assessment, administration, monitoring and patient education provides the foundation for effective management of patients receiving epoetin alfa therapy.
Rieger
P T
PT
Division of Medicine/Clinical Immunology and Biological Therapy, University of Texas M.D. Anderson Cancer Center, Houston.
Haeuber
D
D
D000740:Anemia / Q000139:chemically induced / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D010347:Patient Care Planning
D000970:Antineoplastic Agents; D004921:Erythropoietin